NCT07453394 2026-03-06QLS5132 Combination Therapy in Advanced Solid TumorsQilu Pharmaceutical Co., Ltd.Phase 1/2 Not yet recruiting626 enrolled
NCT06963502 2025-05-09A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid TumorsJiangsu Hansoh Pharmaceutical Co., Ltd.Phase 1 Not yet recruiting762 enrolled
NCT06142617 2023-11-21A Prospective Study of Pembrolizumab Combining Chemotherapy in Advanced NSCLC Patients With EGFR Exon 21 Point Mutation.Peking Union Medical College HospitalPhase 2 Not yet recruiting37 enrolled